Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus

Y. F. Lu, K. Tomizawa, A. Moriwaki, Y. Hayashi, M. Tokuda, T. Itano, O. Hatase, H. Matsui

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Abstract

The effects of FK506, a Ca2+/calmodulin-dependent phosphatase 2B (calcineurin) inhibitor, on the NMDA receptor-mediated potentials and synaptic plasticity were investigated in the CA1 region of the rat hippocampus. Bath application of FK506 (50 μM) produced a 45% inhibition on the NMDA receptor-mediated potentials. FK506 also inhibited the induction of long-term potentiation (LTP), but had no effect on the depotentiation in the CA1 hippocampus. Cyclosporin A (100 μM), another calcineurin inhibitor, mimicked the effects of FK506 on the NMDA responses and synaptic plasticity. These results suggest that FK506 inhibits the activity of NMDA receptors via the involvement of calcineurin. The differential effects of FK506 on LTP and depotentiation may attribute to the partial inhibition on the activity of NMDA receptors and the subsequent attenuation of intracellular Ca2+ increase.

Original languageEnglish
Pages (from-to)142-146
Number of pages5
JournalBrain Research
Volume729
Issue number1
DOIs
Publication statusPublished - Aug 5 1996

Keywords

  • Calcineurin
  • Cyclosporin A
  • Depotentiation
  • FK506
  • Hippocampus
  • Long-term potentiation
  • N-Methyl-D-aspartate (NMDA) receptor
  • Synaptic plasticity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint

Dive into the research topics of 'Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus'. Together they form a unique fingerprint.

Cite this